Metabolomics fingerprinting of thyroid malignancies: a GC/MS-based approach for subtype classification and biomarker discovery #BMCCancer bmccancer.biomedcentral.com/articles/10....
Metabolomics fingerprinting of thyroid malignancies: a GC/MS-based approach for subtype classification and biomarker discovery - BMC Cancer
Background Thyroid cancer encompasses distinct histological subtypes, each potentially associated with unique metabolic characteristics. However, the comprehensive metabolic reprogramming underlying t...
bmccancer.biomedcentral.com
October 16, 2025 at 10:14 AM
Metabolomics fingerprinting of thyroid malignancies: a GC/MS-based approach for subtype classification and biomarker discovery #BMCCancer bmccancer.biomedcentral.com/articles/10....
Identification of novel serum lipid metabolism potential markers and metabolic pathways for oral cancer: a population-based study #BMCCancer #MassSpec bmccancer.biomedcentral.com/articles/10....
Identification of novel serum lipid metabolism potential markers and metabolic pathways for oral cancer: a population-based study - BMC Cancer
Objective This study aims to identify potential lipid biomarkers and metabolic pathways associated with oral cancer (OC). Then to establish and evaluate disease classification models capable of distin...
bmccancer.biomedcentral.com
January 31, 2025 at 8:22 AM
Identification of novel serum lipid metabolism potential markers and metabolic pathways for oral cancer: a population-based study #BMCCancer #MassSpec bmccancer.biomedcentral.com/articles/10....
A #BMCCancer study of high-risk breast cancer patients reveals a crucial gap in care: patients need personalized, tailored info at every stage of genetic testing 🧬
Read more here: https://bit.ly/4ghL9NE
@bmc.springernature.com
Read more here: https://bit.ly/4ghL9NE
@bmc.springernature.com
August 26, 2026 at 10:50 PM
A #BMCCancer study of high-risk breast cancer patients reveals a crucial gap in care: patients need personalized, tailored info at every stage of genetic testing 🧬
Read more here: https://bit.ly/4ghL9NE
@bmc.springernature.com
Read more here: https://bit.ly/4ghL9NE
@bmc.springernature.com
#OncologyNurses: A study in #BMCCancer on hereditary breast cancer genetic testing shows patients’ info needs vary greatly by coping style! 🧬🩺
One size does not fit all when it comes to patient care. Read more data from the study here: https://bit.ly/4ghL9NE
One size does not fit all when it comes to patient care. Read more data from the study here: https://bit.ly/4ghL9NE
Informational Needs Vary at Every Stage of Genetic Testing for Breast Cancer - Oncology Nurse Advisor
A qualitative study evaluated the information-seeking behaviors of patients undergoing genetic testing for hereditary breast cancer.
bit.ly
August 18, 2026 at 6:22 PM
#OncologyNurses: A study in #BMCCancer on hereditary breast cancer genetic testing shows patients’ info needs vary greatly by coping style! 🧬🩺
One size does not fit all when it comes to patient care. Read more data from the study here: https://bit.ly/4ghL9NE
One size does not fit all when it comes to patient care. Read more data from the study here: https://bit.ly/4ghL9NE
Serum untargeted metabolomics analysis of colorectal cancer #BMCCancer #MassSpec link.springer.com/article/10.1...
Serum untargeted metabolomics analysis of colorectal cancer - BMC Cancer
Background Colorectal cancer (CRC) is a prevalent gastrointestinal tract disease with atypical manifestations. The objective of this study was to employ serum metabolomics for the identification of po...
link.springer.com
December 16, 2025 at 8:18 PM
Serum untargeted metabolomics analysis of colorectal cancer #BMCCancer #MassSpec link.springer.com/article/10.1...
Plasma lipidomics for biomarker identification in non-muscle invasive bladder cancer #BMCCancer #MassSpec bmccancer.biomedcentral.com/articles/10....
Plasma lipidomics for biomarker identification in non-muscle invasive bladder cancer - BMC Cancer
Background Bladder cancer is a high-incidence malignant tumor in the world. Currently available potential biomarkers lack sufficient diagnostic accuracy, underscoring the need for novel biomarkers. Li...
bmccancer.biomedcentral.com
November 5, 2025 at 12:31 PM
Plasma lipidomics for biomarker identification in non-muscle invasive bladder cancer #BMCCancer #MassSpec bmccancer.biomedcentral.com/articles/10....
Metabolic characteristics of benign and malignant pulmonary nodules and establishment of invasive lung adenocarcinoma model by high-resolution mass spectrometry #BMCCancer bmccancer.biomedcentral.com/articles/10....
Metabolic characteristics of benign and malignant pulmonary nodules and establishment of invasive lung adenocarcinoma model by high-resolution mass spectrometry - BMC Cancer
Background Increasing pulmonary nodule presentations in lung adenocarcinoma patients reveal diagnostic limitations of CT-based invasiveness assessment. The critical unmet need lies in developing non-i...
bmccancer.biomedcentral.com
May 9, 2025 at 7:59 PM
Metabolic characteristics of benign and malignant pulmonary nodules and establishment of invasive lung adenocarcinoma model by high-resolution mass spectrometry #BMCCancer bmccancer.biomedcentral.com/articles/10....
Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma #BMCCancer #MassSpec bmccancer.biomedcentral.com/articles/10....
Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma - BMC Cancer
Background Reprogramming of cellular metabolism is a pivotal mechanism employed by tumor cells to facilitate cell growth, proliferation, and differentiation, thereby propelling the progression of canc...
bmccancer.biomedcentral.com
December 6, 2024 at 7:41 PM
Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma #BMCCancer #MassSpec bmccancer.biomedcentral.com/articles/10....
So frustrated 😡 with @BMC_series #BMCCancer. Resubmitted a minor revision >6 MONTHS ago. Journal confirmed reviewers responded to our revision in OCT! but still no decision. No explanation! Withdrawing manuscript, but devastating for #postdoc authors looking for jobs.
May 3, 2025 at 9:01 PM
So frustrated 😡 with @BMC_series #BMCCancer. Resubmitted a minor revision >6 MONTHS ago. Journal confirmed reviewers responded to our revision in OCT! but still no decision. No explanation! Withdrawing manuscript, but devastating for #postdoc authors looking for jobs.